Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Oxymetazoline hydrochloride 500 microgram/mL nasal spray |
Is a |
False |
Oxymetazoline hydrochloride |
Inferred relationship |
Some |
|
Oxymetazoline hydrochloride 500 microgram/mL nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxymetazoline hydrochloride |
Inferred relationship |
Some |
|
Oxymetazoline hydrochloride 0.025% nose drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxymetazoline hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely oxymetazoline hydrochloride 2.5 milligram/1 milliliter conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxymetazoline hydrochloride |
Inferred relationship |
Some |
|
Oxymetazoline hydrochloride 0.05% nose drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxymetazoline hydrochloride |
Inferred relationship |
Some |
|
Oxymetazoline hydrochloride 500 microgram/mL nasal spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxymetazoline hydrochloride |
Inferred relationship |
Some |
1 |
Oxymetazoline hydrochloride 500 microgram/mL nasal spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxymetazoline hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely oxymetazoline hydrochloride 2.5 milligram/1 milliliter conventional release nasal spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxymetazoline hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely oxymetazoline hydrochloride 2.5 milligram/1 milliliter conventional release nasal spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxymetazoline hydrochloride |
Inferred relationship |
Some |
1 |
Oxymetazoline hydrochloride 250 microgram/mL nasal solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxymetazoline hydrochloride |
Inferred relationship |
Some |
1 |
Oxymetazoline hydrochloride 250 microgram/mL nasal solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxymetazoline hydrochloride |
Inferred relationship |
Some |
1 |
Oxymetazoline hydrochloride 500 microgram/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxymetazoline hydrochloride |
Inferred relationship |
Some |
1 |
Oxymetazoline hydrochloride 500 microgram/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxymetazoline hydrochloride |
Inferred relationship |
Some |
1 |
Oxymetazoline hydrochloride 500 microgram/mL nasal solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxymetazoline hydrochloride |
Inferred relationship |
Some |
1 |
Oxymetazoline hydrochloride 500 microgram/mL nasal solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxymetazoline hydrochloride |
Inferred relationship |
Some |
1 |